• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

Serum Osteoinductive Factor as potential Marker of Nephropathy in Type 1 Diabetes Mellitus

    Mohamed Fouad A. Ayoub, Mohamed Abdelaziz Gendia, Ahmed Anwar Shahin, Tamer Abdel Tawab Hasan, Ahmed Abdallah Mohamed Kadoos, Nevin Sherif Ali

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 1506-1514

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: The association among serum osteoinductive factor (OIF) and diabetic nephropathy (DN) and its possible usage as a diagnostic marker for DN should be investigated. Subjects and methods: This study included a total of 60 type 1 diabetic patients divided to normoalbuminuria, microalbuminuria and macroalbuminuria groups , each group contained 20 patients in addition to 20 healthy control subjects. ELISA has examined serum OIF levels and checked other clinical biochemical parameters on the basis of standard methods. Results: The concentration of OIF in microalbuminuric and macroalbuminuric patients was substantially higher than in normoalbuminuric patients and control groups. The study showed significant positive correlation between serum OIF, DM duration, Creatinine and UACR but significantly negative correlated with eGFR and onset of diabetes. Conclusion: Our results indicated that OIF was demonstrated in early stages of DN in T1DM even before appearance of     microalbuminuria and increased with progression   of diabetic nephropathy. So OIF can be used as a biomarker for detection of DN in T1DM in microalbuminuric patients.
Keywords:
  • PDF (210 K)
  • XML
(2020). Serum Osteoinductive Factor as potential Marker of Nephropathy in Type 1 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 7(8), 1506-1514.
Mohamed Fouad A. Ayoub, Mohamed Abdelaziz Gendia, Ahmed Anwar Shahin, Tamer Abdel Tawab Hasan, Ahmed Abdallah Mohamed Kadoos, Nevin Sherif Ali. "Serum Osteoinductive Factor as potential Marker of Nephropathy in Type 1 Diabetes Mellitus". European Journal of Molecular & Clinical Medicine, 7, 8, 2020, 1506-1514.
(2020). 'Serum Osteoinductive Factor as potential Marker of Nephropathy in Type 1 Diabetes Mellitus', European Journal of Molecular & Clinical Medicine, 7(8), pp. 1506-1514.
Serum Osteoinductive Factor as potential Marker of Nephropathy in Type 1 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 2020; 7(8): 1506-1514.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 60
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus